Please wait...
About This Project
We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.
Browse Other Projects on Experiment
Related Projects
Dicty World Race - finding the fastest and smartest Dicty cells
On May 16, Dicty and HL60 cells will race for the "fastest &smartest" title. Both cell types are models...
How do cataracts form and how can they be prevented?
Cataract is the leading cause of blindness worldwide. The lens in our eye is important for focusing images...
Assessing barriers to meaningful use of electronic health records in South Carolina's small rural practices
We are studying the challenges small practices in rural areas encounter with using Electronic Health Records...